Oncogenes in human primary hepatic cancer

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Oncogenes play a critical role in cancer development.
• The N-ras gene is implicated in various human cancers.
• Understanding oncogene involvement in primary hepatic cancer (PHC) is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the presence and activity of the N-ras gene in human primary hepatic cancer (PHC).
• To explore the potential role of N-ras and c-myc in the pathogenesis of PHC.
• To analyze N-ras gene alterations and expression levels in PHC specimens.

Main Methods:

• Transfection assays using NIH 3T3 cells with DNA from PHC specimens and hepatoma cell lines.
• Identification of human N-ras gene in transfectants.
• Analysis of N-ras gene expression via poly(A)+RNA, P21 synthesis, and gene rearrangement/amplification in PHC tissues.

Main Results:

• Positive transfection results and identification of the N-ras gene in 7402 cells and 60% of PHC DNA samples.
• Enhanced N-ras expression and elevated P21 synthesis observed in PHC tissues and transfectants.
• N-ras gene rearrangement and amplification detected in two PHC samples; high c-myc expression noted in most PHC tissues.

Conclusions:

• The N-ras gene is present and active in a significant proportion of human primary hepatic cancer (PHC) cases.
• Cooperating activity between N-ras and c-myc may contribute to the malignant phenotype in PHC.
• Further research is warranted to elucidate the precise mechanisms and therapeutic implications of N-ras and c-myc in liver cancer.